Trial · NCT04095104
Results by group55
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 55
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Enrollment Rate | All Eligible Participants Before Randomization | 19 | percentage of participants | ||
| Dropout Rate | Phentermine & Topiramate | 0 | percentage who withdrew among enrolled | ||
| Dropout Rate | Placebo | 7.7 | percentage who withdrew among enrolled | ||
| Number of Participants Adherent to Study Drugs | Phentermine & Topiramate | 5 | Participants | ||
| Number of Participants Adherent to Study Drugs | Placebo | 0 | Participants | ||
| Frequency of Adverse Events | Phentermine & Topiramate | 16 | Full Range 10 to 27 | unique adverse events per participant | |
| Frequency of Adverse Events | Placebo | 8 | Full Range 1 to 16 | unique adverse events per participant | |
| Percent BMI Change | Phentermine & Topiramate | -3.61 | Full Range -13 to 2.86 | percent change | |
| Percent BMI Change | Placebo | 1.89 | Full Range -0.06 to 4.62 | percent change | |
| Percent Weight Change | Phentermine & Topiramate | -4.72 | Full Range -12.14 to 2.61 | percent change | |
| Percent Weight Change | Placebo | 0.83 | Full Range -6.94 to 6.47 | percent change | |
| Change in BMI Percent of the 95th%Ile | Phentermine & Topiramate | -6.2 | Full Range -19 to 4 | percentile change | |
| Change in BMI Percent of the 95th%Ile | Placebo | 2 | Full Range 0 to 4 | percentile change | |
| Change in Heart Rate | Phentermine & Topiramate | 2.89 | Full Range -16.67 to 47.33 | beats per minute | |
| Change in Heart Rate | Placebo | -0.83 | Full Range -16 to 6.33 | beats per minute | |
| Change in Systolic Blood Pressure | Phentermine & Topiramate | 3.33 | Full Range -4 to 23 | mmHg | |
| Change in Systolic Blood Pressure | Placebo | 0.78 | Full Range -6.67 to 10 | mmHg | |
| Change in Diastolic Blood Pressure | Phentermine & Topiramate | -1.33 | Full Range -20 to 11.67 | mmHg | |
| Change in Diastolic Blood Pressure | Placebo | 4.17 | Full Range -6.67 to 20.67 | mmHg | |
| Change in Total Cholesterol (mg/dL) | Phentermine & Topiramate | -18 | Full Range -47 to 33 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04095104/results